THERMO RECENT VIDEOS AND WEBINARS
Maintaining Process Consistency And Performance During Scale-Up
See how an intensified N-1 perfusion process maintained stable cultures, reproducible cell expansion, and aligned mAb production across 5 L, 50 L, and 500 L scales while supporting viable cell densities.
Accelerating CHO Media Development: From Screening To AI Design
Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.
Evaluating Modular CAR T Manufacturing Workflows
As CAR T manufacturing scales, balancing throughput, flexibility, and cell quality becomes increasingly complex. Explore strategies for improving process control, reducing bottlenecks, and more.
Driving Productivity Across The Antibody Manufacturing Workflow
Learn how integrated upstream and downstream strategies can reduce harvest bottlenecks, improve purification efficiency, and support scalable therapeutic antibody manufacturing.
De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing
Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.
Driving Measurable Productivity Gains In CHO Cell Culture
Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.
The Future Of Cell Culture Media Development
Predictive modeling and AI are helping reshape cell culture media. Learn how these approaches can focus experimental efforts, accelerate learning, and support more efficient development decisions.
From Data To Decisions: AI And Multi-Omics For Cell Culture Development
See how combining multi-omics data, AI-enabled analytics, and expertise can reveal the biological drivers of process performance, helping biologics developers identify optimization opportunities.
How Modular Workflows Are Redefining CAR T Manufacturing
Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.
Reducing Particulate-Related Batch Risk In Bioprocessing
Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.
How Intensified Upstream Processing Improves Scale-Up And Tech Transfer
Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.
Generate Stable High-Producing Clones In 14 Weeks
Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.
Using Residual DNA Quantification Data To De-Risk mAb Development
Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.
Efficient mAb Development With A Flexible Purification Toolkit
Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.